Repare Therapeutics Inc. Marketable Securities (Current)
Repare Therapeutics Inc. had Marketable Securities (Current) of $39.78 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-11-14
- 2025-09-30: Marketable Securities, Current $39.78M.
- 2025-06-30: Marketable Securities, Current $41.82M.
- 2025-03-31: Marketable Securities, Current $39.77M.
- 2024-12-31: Marketable Securities, Current $68.07M.
| Period end | Marketable Securities, Current |
|---|---|
| 2025-09-30 | $39.78M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $41.82M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $39.77M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $68.07M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $98.89M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $128.30M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $133.78M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $112.36M 10-K · filed 2025-03-03 |
| 2023-09-30 | $142.70M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $165.15M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $192.66M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $184.42M 10-K · filed 2024-02-28 |
| 2022-09-30 | $215.16M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $6.25M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $6.53M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $7.44M 10-K · filed 2023-02-28 |
| 2021-09-30 | $7.19M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $7.16M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $7.50M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $7.53M 10-K · filed 2022-03-01 |